Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Am J Phys Med Rehabil ; 91(12): 1020-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22854901

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate whether early treatment with carbamazepine decreases the incidence of neuropathic pain (NP) or its intensity in patients with spinal cord injury. DESIGN: This study was a randomized, double-blind, placebo-controlled clinical trial at a third-level university hospital involving patients older than 18 yrs with a diagnosis of spinal cord injury sustained within 2 wks before enrollment and without evidence of NP. The patients received either carbamazepine up to 600 mg/day or placebo for 1 mo. Pain intensity was measured with a 10-cm visual analog scale and the SF-36 bodily pain subscale; quality-of-life, with the Short Form 36 (SF-36) Scale; and depression, with the Zung Self-Rating Depression Scale. Measurements were carried out at the start of the randomized trial and at the 1-, 3-, and 6-month follow-up assessments. RESULTS: Twenty-one of 46 patients developed NP. At the 1-, 3-, and 6-month follow-up assessments, NP was present in 4, 11, and 10 patients of the carbamazepine group and in 8, 9, and 8 patients of the placebo group, respectively. At 1 mo, two patients in the carbamazepine group vs. eight patients in the placebo group reported moderate/intense pain (visual analog scale, ≥4.0; P = 0.024). At the 3- and 6-month follow-up appointments, moderate/intense pain was reported by eight vs. six (P = 0.498) and six vs. eight patients (P = 0.298), carbamazepine and placebo group, respectively. There was no difference in the depression ratings or in any of the SF-36 scales. CONCLUSIONS: Early intervention with carbamazepine decreased NP incidence at the 1-month but not at the 3- and 6-month follow-ups in the group of patients with acquired spinal cord injury.


Subject(s)
Analgesics, Non-Narcotic/therapeutic use , Carbamazepine/therapeutic use , Neuralgia/prevention & control , Adolescent , Adult , Aged , Female , Health Status Indicators , Humans , Male , Middle Aged , Neuralgia/etiology , Pain Measurement , Spinal Cord Injuries/complications , Time Factors , Young Adult
2.
Iatreia ; 20(2): 144-159, jun. 2007.
Article in Spanish | LILACS | ID: lil-461348

ABSTRACT

El dolor lumbar es un motivo muy común de consulta médica; debido a la amplia oferta de opciones terapéuticas, es importante recurrir a los conceptos de la medicina basada en la evidencia para seleccionar las mejores.Las intervenciones que cuentan con evidencias más sólidas en la literatura son: mantenerse activo, hacer ejercicio durante los cuadros subagudo y crónico así como después de la cirugía, los antiinflamatorios no esteroides (AINE) y los antidepresivos.


Low back pain is a very common reason for consultation in general practice; due to the wide offer of treatment options, it is important, in order to select the best, to resort to the concepts of evidence-based medicine. The interventions that have more solid evidence in the literature are: to keep being active, to prescribe therapeutic exercises during the subacute and chronic periods, as well as after surgery, and to use non-steroidal antiinflammatories and antidepressants.


Subject(s)
Low Back Pain , Evidence-Based Medicine
3.
BOGOTA; s.n; abr; oct. 1997. 50 p. tab, graf.
Non-conventional in Spanish | LILACS | ID: lil-237796
SELECTION OF CITATIONS
SEARCH DETAIL
...